Mitoquinone

DRUG3 trials

Sponsors

Oregon Health and Science University, D'Or Institute for Research and Education, VA Office of Research and Development

Conditions

Breast NeoplasmsFatigueLong-COVIDMultiple Sclerosis

Phase 1

MitoQ for Fatigue in Multiple Sclerosis

TerminatedNCT03166800

Oregon Health and Science UniversityFatigue, Multiple Sclerosis

Start: 2018-09-15End: 2019-01-10Updated: 2023-04-05

Unknown Phase

The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

D'Or Institute for Research and EducationBreast Neoplasms

Start: 2022-06-02End: 2023-12-02Target: 44Updated: 2022-04-08

Long-term COVID and Rehabilitation

RecruitingNCT05373043

VA Office of Research and DevelopmentLong-COVID

Start: 2022-11-01End: 2028-10-31Target: 300Updated: 2026-07-30